Universität Lausanne, 2008. — 1 р.
Die unten aufgeführten Medikamente sind bekannt dafür, dass sie bei gewissen Personen das QT-Intervall auf dem Elektrokardiogramm verlängern. Deshalb können diese Medikamente folgenschwere Herzrhythmusstörungen verursachen. Aufgrund der bei Ihnen gestellten Diagnose sind diese Medikamente für Sie kontraindiziert. Das heisst, die Einnahme ist...
Elsevier Science, 2009 - 842 p. 15-е издание энциклопедии Meyler’s Side Effect of Drugs. Разделы: препараты для лечения артериальной гипертензии, сердечной недостаточности, стенокардии, диуретики, антиаритмические препараты, препараты, влияющие на церебральное и периферическое артериальное и венозное кровообращение, антикоагулянты, тромболитики, антитромбоцитарные препараты,...
Bentham Science Publishers Ltd., UAE, 2016. — 406 p. — ISBN: 1681081644. Frontiers in Cardiovascular Drug Discovery is an eBook series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throu. Frontiers in Cardiovascular Drug Discovery is an...
Springer, 2015. — 506 p. — (Current Cardiovascular Therapy) — ISBN: 978-3-319-17332-0 This book is intended for general cardiologists and other physicians involved in the care of patients with chronic stable angina (CSA). The goal of this book is to update clinicians on recent data on the medical management of patients with CSA. Ischemic heart disease remains a major public health...
9th edition. — Elsevier, 2021. — 659 p. — ISBN 978-0-323673617. Authoritative, portable, and up to date, Opie’s Cardiovascular Drugs, 9th Edition, is the definitive reference for quick access to frequently used drugs in all phases of care for cardiac patients. Now a part of the Braunwald family of renowned cardiology references, this compact title provides crucial information...
ITexLi, 2018. — 111 p. — ISBN 1789236231 9781789236231 1789236223 9781789236224 1838814981 9781838814984. This book provides an extensive overview of all the known anticoagulants that can be useful for studying different aspects of the haemostatic system or as a starting point for new drug development. It is also a valuable tool for clinicians providing a description of the...
Academic Press, 2021. — 212 p. — ISBN 978-0-12-820536-5. Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease is a complete reference containing updated information on the advantages and disadvantages of dual antiplatelet therapy, its duration, composition and anticipated changes. The basis for DAPT in arterial disease is discussed, allowing readers to...
Springer, 2018. — 305 p. — (Updates in Hypertension and Cardiovascular Protection). This book provides a critical and comprehensive review of the methodologies available for measuring drug adherence in clinical practice, including those relying on emerging technologies. The authors discuss the risk factors of non-adherence and shed light on how to identify patients at risk of...
Bentham Science Publishers, 2022. — 256 p. — ISBN 978-981-5036-92-3. Frontiers in Cardiovascular Drug Discovery is a book series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents,...
2nd edition. — American Society of Health-System Pharmacists, 2018. — 683 p. Although highly effective in preventing thromboembolic events, the safe management of anticoagulant therapy continues to be a major challenge, requiring constant monitoring and coordinated models of patient-centered care. Anticoagulation Therapy: A Clinical Practice Guide, Second Edition, helps take...
American Society of Health-System Pharmacists, 2018. — 682 p. Anticoagulation therapy is an area of high impacts for pharmacists. Anticoagulants (blood thinners) require constant monitoring for renal function, pharmacokinetics, and interactions with other medicines. In some ways, these drugs can be considered a double-edged sword - while they save thousands of lives by...
Springer, 2015. — 281 p. — (Current Cardiovascular Therapy). — ISBN 978-3-319-09554-7. This book is driven by the considerable progress made by novel imaging techniques in understanding the pathophysiology and evolution of aortic disease and its diagnosis. Despite the lack of symptoms in stable conditions, most aortic diseases have a high morbidity and mortality. New...
Springer International Publishing, 2015. — 1323 p. — ISBN: 978-3-319-15961-4. With the advance of modern civilization, the historical causes of death in human populations such as war, drought, famine and the spread of microbes have been replaced by a new wave of global killers: ‘non-communicable diseases (NCDs)’. According to the World Health Organization report, NCDs kill 38...
7th edition. — W.B. Saunders, 1995. — 426 p. Features a rationale for the choice of drug in given clinical situations and how best to manage cardiac problems. The format summarizes how the drug is supplied, dosage guidelines, action pharmacokinetics, clinical advice, efficacy, adverse effects, contraindications and interactions.
World Scientific Publishing Company, 2011. — 189 p. — ISBN 978-9814317450 Ensuring the safety of new medical products remains a major challenge for the pharmaceutical industry. Cardiac safety, particularly drug-induced heart rhythm abnormalities, remains an important cause of pipeline attrition and has resulted in countless major product recalls or label changes. The risk of...
Imagine Publishing Ltd., 2024. — 115 p. Bookazine of monthly magazine How It Works. In Amazing Cutaways, we delve deeper into the wonderful worlds of science, technology, transport, history, space and the environment with a selection of some of the best illustrations from the pages of How It Works. Get under the skin of the human body as we find out what happens to our food on...
Oxford University Press, 2011. — 508 p. The book offers a thoroughly reviewed compendium authored by leading experts in the field on the mechanism and consequences of cardiac mechano-electrical coupling. Its coverage ranges from stretch-activated ion channels to mechanically induced arrhythmias and mechanical interventions for heart rhythm correction. Information is grouped into...
New York: Springer, 2018. — 1622 p. This book presents the latest evidence and guidelines supporting the use of anticoagulant therapy for various clinical scenarios. The field of anticoagulation therapy is evolving rapidly, particularly since the arrival and widespread adoption of direct oral anticoagulants. Organized in two parts, this book reviews the pharmacologic properties...
Springer, 2018. — 1622 p. This book presents the latest evidence and guidelines supporting the use of anticoagulant therapy for various clinical scenarios. The field of anticoagulation therapy is evolving rapidly, particularly since the arrival and widespread adoption of direct oral anticoagulants. Organized in two parts, this book reviews the pharmacologic properties of...
Springer, 2020. — 433 p. — (Current Cardiovascular Therapy) — ISBN: 978-3-030-34891-5 This volume reviews current and potential future therapies for arrhythmias. It is a highly practical guide for the use of pharmaceuticals in the management of the discipline, and has been written in a simple quick-access format.Antiarrhythmic Drugs builds on the current understanding of...
Springer, 2021. — 283 p. — ISBN 978-3-030-74461-8. This book concisely covers the latest developments in the application of direct oral anticoagulants (DOACs) within cardiovascular medicine. It details the pharmacodynamics and pharmacokinetic mechanisms of DOACs and their application in treating patients with conditions ranging from coronary heart disease through kidney disease...
Springer, 2021. — 785 p. — ISBN 978-3-030-74462-5. This book concisely covers the latest developments in the application of direct oral anticoagulants (DOACs) within cardiovascular medicine. It details the pharmacodynamics and pharmacokinetic mechanisms of DOACs and their application in treating patients with conditions ranging from coronary heart disease through kidney disease...
ADIS, 2015. — 281 p. — ISBN: 978-3-319-22601-9. In addition to acting as a training guide for pharmacists, pharmacy residents and pharmacy students who seek to practice in areas associated with patients on anticoagulant therapy, the information presented within highlights the growing role of the pharmacist in these contexts. Readers will find useful information on anticoagulant...
Springer, 2014. — 141 p. The spectrum of cardiovascular disease affecting women in pregnancy and postpartum is changing and differs between countries. In the western world, the risk of cardiovascular disease in pregnancy has increased due to the increasing age at the first pregnancy and the worldwide obesity epidemic leading also to early diabetes and hypertension. In addition...
4th edition. — Elsevier, 2010. — 1261 p.
Pumping Action and Electrical Activity of the Heart
Cellular Electrophysiology of Heart and Vascular Smooth Muscle
Vascular Endothelium
Excitation–Contraction Coupling and Pharmacomechanical Coupling
Metabolism and Energetics
Signaling Systems
Developmental Changes and Aging
Mechanism of Action of Cardioactive Drugs...
Springer, 2013. — 284 p. Cardiac disorders are an exciting area of classic pathology and recently defined disease. The book discusses the various disorders and also provides a backdrop of developmental embryology, diagnostic imaging and current therapeutics. The book aims to deliver in bench-book format a comprehensive overview of cardiac pathology that is relevant to those...
Wiley-Blackwell, 2014. — 349 p. — ISBN: 978-1-118-27575-7 Edited by a team of the world’s leading interventional cardiologists and educators, this new book is created with an eye to giving the reader a solid, practical, and clinically focused understanding of this important class of drugs, from basic science to a clear-headed discussion of complex topics such as combination...
Springer, 2020. — 345 p. — (Advances in Experimental Medicine and Biology 1177) — ISBN: 978-981-15-2516-2 This book provides an overview of the etiology of coronary artery disease and focuses on the main therapies and drug interventions currently available. It highlights drug pharmacology and therapeutic challenges, with a special emphasis on the underlying principles of...
М.: Медицинское информационное агентство, 2010. – 360 c. – ISBN: 978-5-8948-1796-5. В руководстве представлена научно обоснованная тактика и стратегия применения лекарственных препаратов при наиболее часто встречающихся заболеваниях сердечно-сосудистой системы и патологических синдромах кардиологического профиля. Не останавливаясь подробно на клинической картине заболеваний, их...
Медицинское информационное агентство, 2010. - 360 c.
ISBN: 978-5-8948-1796-5
В руководстве представлена научно обоснованная тактика и стратегия применения лекарственных препаратов при наиболее часто встречающихся заболеваниях сердечно-сосудистой системы и патологических синдромах кардиологического профиля. Не останавливаясь подробно на клинической картине заболеваний, их...
Шымкент: ОҚМФА, 2017. — 145 б. Окулықта аурулардың себептанулары, патогенездері, клиникалық көріністері және дәрілік құралдардың ауруларды дәрілермен емдеудің үлгіқалыптары, олардың номенклатурасы дәрілердің шығарылу түрлері мен дозалау әдістері, сондай-ақ қысқаша фармакотерапиялық сипаттамасы (қолдану көрсеткіштері, колдануға қарама-қарсы көрсеткіштері және әсер ету...
Москва: МАИ, 2013. — 146 с. В монографии в виде ответов на наиболее часто задаваемые вопросы суммированы современные данные о фармакокинетических особенностях бета-адреноблокаторов, их фармакодинамических эффектах, месте в лечении сердечно-сосудистых и несердечно-сосудистых заболеваний, переносимости и влиянии на качество жизни. Книга может быть использована для...
Учебное пособие для кардиологов, терапевтов. — М.: Российская медицинская академия последипломного образования, 2013. — 19 с. Целью данного анализа является представление сравнительных результатов, которые были получены в контролируемых исследованиях с использованием плацебо у больных с наиболее распространенными проявлениями сердечно-сосудистых заболеваний. К ним относятся...
М.: Всероссийское научное общество кардиологов, 2011. – 75 с. Сердечно-сосудистые заболевания по-прежнему составляют основу смертности населения во всех развитых странах мира. В России на долю ССЗ приходится 56,5% всех смертельных исходов, при этом абсолютные показатели смертности от ССЗ в настоящее время в нашей стране в 5-6 раз больше, чем в странах Запада. Хорошо известно,...
М.: 2009. Рекомендации подготовлены Секцией рациональной фармакотерапии ВНОК Рекомендовано Учебно-методическим объединением по медицинскому и фармацевтическому образованию вузов России в качестве учебного пособия для системы послевузовского и дополнительного профессионального образования врачей. Рабочая группа по подготовке текста рекомендаций Председатель - проф. Марцевич С....
Монография. — М.: Академия Естествознания, 2015. — 178 с. — ISBN: 978-5-91327-354-3. В монографии рассматриваются вопросы современной стратегии антигипертензивной терапии. Показано, что интегральные показатели результата антигипертензивной терапии могут быть измерены количественно, при этом их проспективная сравнительная оценка является объективным методом контроля...
Монография. — М.: Академия Естествознания, 2014. — 164 с. — ISBN: 978-5-91327-283-6. Монография посвящена изучению влияния препаратов метаболического действия на биоэлектрическую активность сердца при остром ишемическом инсульте. Приведены данные клинических исследований, обосновывающие целесообразность и безопасность применения отечественного препарата 3-оксипиридина сукцината...
Комментарии